Estimating the number of deaths with rotavirus as a cause in England and Wales

被引:27
作者
Jit, Mark
Pebody, Richard
Chen, Mark
Andrews, Nick
Edmunds, W. John
机构
[1] Hlth Protect Agcy, Ctr Infect, Modelling & Econ Unit, London NW9 6HT, England
[2] Hlth Protect Agcy, Ctr Infect, Immunisat Dept, London NW9 6HT, England
[3] Hlth Protect Agcy, Ctr Infect, Stat Unit, London NW9 6HT, England
来源
HUMAN VACCINES | 2007年 / 3卷 / 01期
关键词
child mortality; gastroenterititis; regression analysis; rotavirus; rotavirus vaccines (all MeSH terms); EFFICACY; DISEASE; VACCINE; SAFETY;
D O I
10.4161/hv.3.1.3748
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The precise number of deaths due to rotavirus infection in England and Wales is difficult to determine because mortality is usually low and reported simply as death due to gastrointestinal disease. We have used two independent methods to estimate this figure. Firstly, we obtained records from the Office for National Statistics of deaths in children with any mention of gostroenteritis. For deaths with uncertain aetiology, we estimated the proportion attributable to rotavirus using a linear model with monthly laboratory reports of gastrointestinal micro-organisms as predictors. Secondly, we calculated the case-fatality ratio of records in Hospital Episode Statistics with rotavirus indicated, and applied this ratio to an estimate of the actual number of rotavirus hospital admissions. The two methods gave estimates of 3.3 and 3.2 rotavirus deaths a year respectively.
引用
收藏
页码:23 / 26
页数:4
相关论文
共 7 条
  • [1] [Anonymous], J INFECT DIS
  • [2] GRANT MT, 1993, HYDROCARBON CONTAM S, V3, P75
  • [3] *OFF NAT STAT, 2002, DH3, V33
  • [4] Global illness and deaths caused by rotavirus disease in children
    Parashar, UD
    Hummelman, EG
    Bresee, JS
    Miller, MA
    Glass, RI
    [J]. EMERGING INFECTIOUS DISEASES, 2003, 9 (05) : 565 - 572
  • [5] Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis
    Ruiz-Palacios, GM
    Pérez-Schael, I
    Velázquez, FR
    Abate, H
    Breuer, T
    Clemens, SC
    Cheuvart, B
    Espinoza, F
    Gillard, P
    Innis, BL
    Cervantes, Y
    Linhares, AC
    López, P
    Macías-Parra, M
    Ortega-Barría, E
    Richardson, V
    Rivera-Medina, DM
    Rivera, L
    Salinas, B
    Pavía-Ruz, N
    Salmerón, J
    Rüttimann, R
    Tinoco, JC
    Rubio, P
    Nuñez, E
    Guerrero, ML
    Yarzábal, JP
    Damaso, S
    Tornieporth, N
    Sáez-Llorens, X
    Vergara, RF
    Vesikari, T
    Bouckenooghe, A
    Clemens, R
    De Vos, B
    O'Ryan, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) : 11 - 22
  • [6] Burden of rotavirus disease in European Union countries
    Soriano-Gabarró, M
    Mrukowicz, J
    Vesikari, T
    Verstraeten, T
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (01) : S7 - S11
  • [7] Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
    Vesikari, T
    Matson, DO
    Dennehy, P
    Van Damme, P
    Santosham, M
    Rodriguez, Z
    Dallas, MJ
    Heyse, JF
    Goveia, MG
    Black, SB
    Shinefield, HR
    Christie, CDC
    Ylitalo, S
    Itzler, RF
    Coia, ML
    Onorato, MT
    Adeyi, BA
    Marshall, GS
    Gothefors, L
    Campens, D
    Karvonen, A
    Watt, JP
    O'Brien, KL
    DiNubile, MJ
    Clark, HF
    Boslego, JW
    Offit, PA
    Heaton, PM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) : 23 - 33